Tadalafil and Erectile Function
Tadalafil belongs to a class of medications called phosphodiesterase type 5 (PDE5) inhibitors. Traditionally, it has been used to treat erectile dysfunction (ED) in cisgender men. However, its mechanism of action – increasing blood flow to the genital area – has proven valuable for transgender women (assigned male at birth) who are undergoing hormone therapy with oestrogen.
Oestrogen treatment often results in reduced erectile function. Transgender women may experience difficulty achieving or maintaining an erection, which can be distressing. Tadalafil can help by improving blood flow to the pelvic region, potentially allowing for improved erectile function when desired. This can contribute to a more fulfilling and affirming sex life.
Tadalafil and Penile Atrophy
Another challenge faced by transgender women on hormone therapy is penile atrophy. Oestrogen therapy typically leads to the shrinking of the genitalia, which can be both physically and emotionally uncomfortable. Tadalafil’s ability to increase blood flow to the area may help mitigate this side effect, maintaining penile size and functionality.
Tadalafil and Improved Sexual Satisfaction
In addition to its physiological benefits, tadalafil can also enhance the sexual satisfaction of transgender individuals undergoing hormone therapy. A more robust blood supply to the genital area can result in increased sensitivity and pleasure during sexual activity.
Dosage and Administration
The dosage of tadalafil in gender-affirming care may vary depending on individual needs. It is typically taken on an as-needed basis, with the dosage ranging from 2.5 mg to 20 mg, usually about 30 minutes before sexual activity. However, healthcare providers may adjust the dose according to the person’s specific situation.